Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy
出版年份 2019 全文链接
标题
Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy
作者
关键词
-
出版物
Nature Biomedical Engineering
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-23
DOI
10.1038/s41551-019-0431-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
- (2019) Shayesteh R. Ferdosi et al. Nature Communications
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation
- (2018) Ana M. Moreno et al. MOLECULAR THERAPY
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy
- (2017) Hildegund C.J. Ertl et al. HUMAN GENE THERAPY
- Regulatory and Exhausted T Cell Responses to AAV Capsid
- (2017) Gwladys Gernoux et al. HUMAN GENE THERAPY
- Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiation
- (2017) Franziska Zabel et al. IMMUNOLOGY
- Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1
- (2017) Anna Majowicz et al. MOLECULAR THERAPY
- Diversity and evolution of class 2 CRISPR–Cas systems
- (2017) Sergey Shmakov et al. NATURE REVIEWS MICROBIOLOGY
- Immunity to CRISPR Cas9 and Cas12a therapeutics
- (2017) Wei Leong Chew Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Therapeutic genome engineering via CRISPR-Cas systems
- (2017) Ana M. Moreno et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
- (2016) Angelo Amabile et al. CELL
- Surveying the Delivery Methods of CRISPR/Cas9 for ex vivo Mammalian Cell Engineering
- (2016) William J. Kelton et al. CHIMIA
- New CRISPR–Cas systems from uncultivated microbes
- (2016) David Burstein et al. NATURE
- Analyzing CRISPR genome-editing experiments with CRISPResso
- (2016) Luca Pinello et al. NATURE BIOTECHNOLOGY
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
- (2016) Hok Hei Tam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A large fraction of HLA class I ligands are proteasome-generated spliced peptides
- (2016) Juliane Liepe et al. SCIENCE
- Direct measurement of T cell receptor affinity and sequence from naïve antiviral T cells
- (2016) Shu-Qi Zhang et al. Science Translational Medicine
- AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees
- (2016) Roberto Calcedo et al. Human Gene Therapy Clinical Development
- Viral Vectors for Gene Therapy: Translational and Clinical Outlook
- (2015) Melissa A. Kotterman et al. Annual Review of Biomedical Engineering
- Gapped sequence alignment using artificial neural networks: application to the MHC class I system
- (2015) Massimo Andreatta et al. BIOINFORMATICS
- Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads
- (2015) Regina S. Salvat et al. BIOTECHNOLOGY AND BIOENGINEERING
- Early Interaction of Adeno-Associated Virus Serotype 8 Vector with the Host Immune System Following Intramuscular Delivery Results in Weak but Detectable Lymphocyte and Dendritic Cell Transduction
- (2015) Gwladys Gernoux et al. HUMAN GENE THERAPY
- Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification
- (2015) Massimo Andreatta et al. IMMUNOGENETICS
- Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
- (2015) Sergey Shmakov et al. MOLECULAR CELL
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- An updated evolutionary classification of CRISPR–Cas systems
- (2015) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Development of an intein-mediated split–Cas9 system for gene therapy
- (2015) Dong-Jiunn Jeffery Truong et al. NUCLEIC ACIDS RESEARCH
- In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
- (2015) Eric Zinn et al. Cell Reports
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
- (2014) Qiurong Ding et al. CIRCULATION RESEARCH
- The immune epitope database (IEDB) 3.0
- (2014) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- Classification and evolution of type II CRISPR-Cas systems
- (2014) Krzysztof Chylinski et al. NUCLEIC ACIDS RESEARCH
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
- (2013) Vibha Jawa et al. CLINICAL IMMUNOLOGY
- In vivo assessment of specific cytotoxic T lymphocyte killing
- (2013) T. Clemente et al. METHODS
- Adeno-associated Virus-mediated Rescue of Neonatal Lethality in Argininosuccinate Synthetase-deficient Mice
- (2013) Cindy Y Kok et al. MOLECULAR THERAPY
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
- (2013) Seung Woo Cho et al. NATURE BIOTECHNOLOGY
- Cas9 as a versatile tool for engineering biology
- (2013) Prashant Mali et al. NATURE METHODS
- Challenges and approaches for the development of safer immunomodulatory biologics
- (2013) Jean G. Sathish et al. NATURE REVIEWS DRUG DISCOVERY
- Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems
- (2013) Ines Fonfara et al. NUCLEIC ACIDS RESEARCH
- Genetic measurement of memory B-cell recall using antibody repertoire sequencing
- (2013) C. Vollmers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Exploring the MHC-peptide matrix of central tolerance in the human thymus
- (2013) Eleni Adamopoulou et al. Nature Communications
- RNA-programmed genome editing in human cells
- (2013) Martin Jinek et al. eLife
- Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
- (2012) F Mingozzi et al. GENE THERAPY
- Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates
- (2012) Carmen Unzu et al. Journal of Translational Medicine
- Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B
- (2012) Federico Mingozzi et al. MOLECULAR THERAPY
- Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- (2012) G. Gasiunas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine
- (2011) J H McIntosh et al. GENE THERAPY
- Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5
- (2011) C. E. Harbison et al. JOURNAL OF GENERAL VIROLOGY
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
- (2011) Federico Mingozzi et al. NATURE REVIEWS GENETICS
- PEGylation of therapeutic proteins
- (2010) Simona JevsÌevar et al. Biotechnology Journal
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- The Complex and Evolving Story of T cell Activation to AAV Vector-encoded Transgene Products
- (2010) Lauren E Mays et al. MOLECULAR THERAPY
- The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice
- (2009) Jiangao Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
- Predicting linear B‐cell epitopes using string kernels
- (2008) Yasser EL‐Manzalawy et al. JOURNAL OF MOLECULAR RECOGNITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started